A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

NCT02942381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

IgA Patients
Hydroxychloroquine

Interventions

DRUG: Hydroxychloroquine Sulfate
DRUG: Placebo

Sponsor

Peking University First Hospital